103 - IMPACTO GLOBAL DA FALSIFICAÇÃO DE CANETAS EMAGRECEDORAS NA SAÚDE

Doi: 10.47094/978-65-284-0654-8/1036-1041

PALAVRAS CHAVE: Medicamentos Falsificados. Agonistas do Receptor de Peptídeo Semelhante ao Glucagon 1. Farmacovigilância.

KEYWORDS: Counterfeit Drugs. Glucagon-Like Peptide-1 Receptor Agonists. Pharmacovigilance.

ABSTRACT:
The increasing use of weight-loss pens for the treatment of type 2 diabetes and obesity has generated high demand, while supply shortages and the high cost of these products have created favorable conditions for the illegal marketing of counterfeit products through digital platforms and social media. This study aimed to characterize the counterfeiting of weight-loss injection pens on a global scale and to discuss their potential impacts on the population. A descriptive and retrospective analysis was conducted based on internet searches for information from government agencies, manufacturers, and specialized press reports. The findings demonstrated the occurrence of sophisticated fraud schemes, including the cloning of legitimate batches intended for export and the replacement of their contents with rapid-acting insulin analogues, exposing patients to risks such as severe hypoglycemia, therapeutic failure, the presence of chemical impurities, and microbial contamination. The study demonstrated that the counterfeiting of weight-loss injection pens constitutes an emerging public health concern, requiring coordinated actions involving traceability, regulatory enforcement, healthcare professional training, and the strengthening of reporting to pharmacovigilance systems.

Autores

• Márcia Lombardo